S

Sarepta Therapeutics
D

SRPT

21.810
USD
1.50
(7.39%)
مغلق
حجم التداول
246,919
الربح لكل سهم
-2
العائد الربحي
-
P/E
-32
حجم السوق
2,131,130,083
أصول ذات صلة
AMGN
AMGN
6.28
(2.16%)
296.49 USD
BIIB
BIIB
3.680
(2.73%)
138.670 USD
BMRN
BMRN
-0.470
(-0.81%)
57.530 USD
GILD
GILD
-0.680
(-0.57%)
118.320 USD
INCY
INCY
0.780
(0.91%)
86.940 USD
I
IONS
0.910
(2.12%)
43.780 USD
R
RCKT
0.01500
(0.50%)
3.04500 USD
REGN
REGN
14.73
(2.60%)
580.63 USD
VRTX
VRTX
2.49
(0.64%)
392.97 USD
المزيد
الأخبار المقالات

العنوان: Sarepta Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.